Joseph Jensen, MD
Dermatology · Midvale, UTNPI 1740281500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 274 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations.
Across 274 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$679
- Pfizer$493
- Galderma Laboratories, L.p.$447
- UCB, Inc.$412
- AbbVie$387
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$331
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,428100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 41 | $679 |
| Pfizer | 45 | $493 |
| Galderma Laboratories, L.p. | 25 | $447 |
| UCB, Inc. | 21 | $412 |
| AbbVie(2 entities) | 25 | $387 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $331 |
| Novartis | 11 | $204 |
| Astellas Pharma US Inc | 13 | $186 |
| Johnson & Johnson | 7 | $169 |
| Sanofi | 8 | $142 |
| Paratek Pharmaceuticals, Inc. | 7 | $126 |
| Amgen | 5 | $110 |
| Lilly USA, LLC | 6 | $107 |
| Dermavant Sciences, Inc. | 6 | $100 |
| Organon | 5 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $59 |
| EPI Health, LLC | 3 | $55 |
| Dermira, Inc. | 4 | $53 |
| LEO Pharma Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Incyte Corporation | 1 | $28 |
| Biofrontera Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Qiagen, LLC | 1 | $12 |
How this compares
$4,428 in reported general payments places this provider in the 75th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 128 | $4,323 |
| Metronidazole | 47 | $3,202 |
| Fluticasone Propionate | 106 | $2,157 |
| Triamcinolone Acetonide | 164 | $1,931 |
| Alclometasone Dipropionate | 51 | $1,824 |
| CiclopiroxCiclopirox Olamine | 45 | $1,590 |
| Betamethasone Dipropionate | 40 | $1,495 |
| Fluocinonide | 44 | $1,484 |
| Ketoconazole | 68 | $1,462 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 91 | $1,417 |
| Clindamycin Phosphate | 38 | $1,044 |
| Tacrolimus | 14 | $996 |
| ValacyclovirValacyclovir Hcl | 31 | $652 |
| Dapsone | 11 | $531 |
| Mupirocin | 63 | $466 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Midvale
- Brian WilliamsMidvale$876K
- Kirk StephensMidvale$5K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.